Hongyan Tong
First Affiliated Hospital of Zhejiang University · The First Affiliated Hospital, Zhejiang University School of Medicine, Chengzhan Campus · First Affiliated Hospital, Zhejiang University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hongyan Tong as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:46 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07914894 · A Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients.Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · not yet recruiting · Paroxysmal Nocturnal Hemoglobinuria · principal investigator
- Ph1NCT07256301 · A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)Shanghai Lanyi Therapeutics Co., Ltd. · recruiting · PNH - Paroxysmal Nocturnal Hemoglobinuria · principal investigator
- Ph2NCT07199855 · Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic LeukemiaZhejiang University · active not recruiting · B-Cell Acute Lymphoblastic Leukemia, Adult · study director
- Ph1NCT07012109 · Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)BeBetter Med Inc · recruiting · Polycythemia Vera · principal investigator
- Ph1NCT06848296 · Phase Ib Clinical Study to Evaluate the Safety and Tolerability of VSA012 Injection in Paroxysmal Nocturnal HemoglobinuriaBisirna Therapeutics Pte. Ltd. · active not recruiting · Paroxysmal Nocturnal Hemoglobinuria (PNH) · principal investigator
- Ph2NCT06764303 · A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria PatientsNanjing Chia-tai Tianqing Pharmaceutical · active not recruiting · Paroxysmal Nocturnal Hemoglobinuria · principal investigator
- Ph3NCT06647862 · IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · recruiting · Chronic Myelomonocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.